Novel fusion genes and chimeric transcripts in ependymal tumors

We have previously identified two ALK rearrangements in a subset of ependymal tumors using a combination of cytogenetic data and RNA sequencing. The aim of this study was to perform an unbiased search for fusion transcripts in our entire series of ependymal tumors. Fusion analysis was performed using the FusionCatcher algorithm on 12 RNA‐sequenced ependymal tumors. Candidate transcripts were prioritized based on the software's filtering and manual visualization using the BLAST (Basic Local Alignment Search Tool) and BLAT (BLAST‐like alignment tool) tools. Genomic and reverse transcriptase PCR with subsequent Sanger sequencing was used to validate the potential fusions. Fluorescent in situ hybridization (FISH) using locus‐specific probes was also performed. A total of 841 candidate chimeric transcripts were identified in the 12 tumors, with an average of 49 unique candidate fusions per tumor. After algorithmic and manual filtering, the final list consisted of 24 potential fusion events. Raw RNA‐seq read sequences and PCR validation supports two novel fusion genes: a reciprocal fusion gene involving UQCR10 and C1orf194 in an adult spinal ependymoma and a TSPAN4‐CD151 fusion gene in a pediatric infratentorial anaplastic ependymoma. Our previously reported ALK rearrangements and the RELA and YAP1 fusions found in supratentorial ependymomas were until now the only known fusion genes present in ependymal tumors. The chimeric transcripts presented here are the first to be reported in infratentorial or spinal ependymomas. Further studies are required to characterize the genomic rearrangements causing these fusion genes, as well as the frequency and functional importance of the fusions. © 2016 Wiley Periodicals, Inc.

[1]  Amar Gajjar,et al.  Radial glia cells are candidate stem cells of ependymoma. , 2005, Cancer cell.

[2]  T. Gingeras.  Implications of chimaeric non-co-linear transcripts , 2009, Nature.

[3]  Erin L. McDearmon,et al.  The genetics of mammalian circadian order and disorder: implications for physiology and disease , 2008, Nature Reviews Genetics.

[4]  Damien C Weber,et al.  Epidemiology of glial and non-glial brain tumours in Europe. , 2012, European journal of cancer.

[5]  J. Philippé,et al.  The YPEL5–PPP1CB fusion transcript is detected in different hematological malignancies and in normal samples , 2015, Leukemia research reports.

[6]  Nallasivam Palanisamy,et al.  Recurrent reciprocal RNA chimera involving YPEL5 and PPP1CB in chronic lymphocytic leukemia , 2013, Proceedings of the National Academy of Sciences.

[7]  J. Rey,et al.  Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors , 1995, International journal of cancer.

[8]  M. Hemler.  Tetraspanin proteins promote multiple cancer stages , 2013, Nature Reviews Cancer.

[9]  Lee T. Sam,et al.  Transcriptome Sequencing to Detect Gene Fusions in Cancer , 2009, Nature.

[10]  J. Sklar,et al.  A Neoplastic Gene Fusion Mimics Trans-Splicing of RNAs in Normal Human Cells , 2008, Science.

[11]  Jeffrey A. Engelman,et al.  Tyrosine kinase gene rearrangements in epithelial malignancies , 2013, Nature Reviews Cancer.

[12]  Gary D Bader,et al.  Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. , 2015, Cancer cell.

[13]  Hui Li,et al.  Chimeric RNAs generated by intergenic splicing in normal and cancer cells , 2014, Genes, chromosomes & cancer.

[14]  B. Johansson,et al.  The emerging complexity of gene fusions in cancer , 2015, Nature Reviews Cancer.

[15]  P. N. Rao,et al.  Guidance for fluorescence in situ hybridization testing in hematologic disorders. , 2007, The Journal of molecular diagnostics : JMD.

[16]  Jeffrey G. Reifenberger,et al.  Direct RNA sequencing , 2009, Nature.

[17]  P. D. de Jong,et al.  A bacterial artificial chromosome library for sequencing the complete human genome. , 2001, Genome research.

[18]  C. Griffin,et al.  Chromosome abnormalities in low-grade central nervous system tumors. , 1992, Cancer genetics and cytogenetics.

[19]  Paul Theodor Pyl,et al.  HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.

[20]  Krishna R. Kalari,et al.  A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines , 2011, Nucleic acids research.

[21]  W. Huber,et al.  which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets , 2011 .

[22]  G. Thiel,et al.  Karyotypes in 90 human gliomas. , 1992, Cancer genetics and cytogenetics.

[23]  G. Reifenberger,et al.  Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. , 1994, The American journal of pathology.

[24]  O. Kallioniemi,et al.  FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data , 2014, bioRxiv.

[25]  R. Verhaak,et al.  The landscape and therapeutic relevance of cancer-associated transcript fusions , 2014, Oncogene.

[26]  Gary D Bader,et al.  Epigenomic alterations define lethal CIMP-positive ependymomas of infancy , 2014, Nature.

[27]  Gary D Bader,et al.  Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. , 2011, Cancer cell.

[28]  Li Ding,et al.  C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma , 2014, Nature.

[29]  Thomas D. Wu,et al.  Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples , 2011, BMC Medical Genomics.

[30]  M. Nykter,et al.  The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastoma. , 2013, The Journal of clinical investigation.

[31]  Qingguo Wang,et al.  Application of next generation sequencing to human gene fusion detection: computational tools, features and perspectives , 2013, Briefings Bioinform..

[32]  L. Klein-Hitpass,et al.  Supratentorial ependymomas of childhood carry C11orf95–RELA fusions leading to pathological activation of the NF-κB signaling pathway , 2014, Acta Neuropathologica.

[33]  Fatih Ozsolak,et al.  RNA sequencing: advances, challenges and opportunities , 2011, Nature Reviews Genetics.

[34]  Robert H. Bell,et al.  From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer , 2012, The Journal of pathology.

[35]  L. Gorunova,et al.  Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity? , 2015, Neuro-oncology.

[36]  Yoo Jin Jung,et al.  The transcriptional landscape and mutational profile of lung adenocarcinoma , 2012, Genome research.

[37]  L. Gorunova,et al.  Genomic characterization of ependymomas reveals 6q loss as the most common aberration , 2014, Oncology reports.

[38]  G. Trøen,et al.  Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12). , 2011, Cancer genetics.

[39]  P. Zaphiropoulos.  Trans-splicing in Higher Eukaryotes: Implications for Cancer Development? , 2011, Front. Gene..

[40]  David R. Kelley,et al.  Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks , 2012, Nature Protocols.

[41]  David Z. Chen,et al.  METHOD Open Access , 2014 .

[42]  A. Fujimoto,et al.  Cancer whole-genome sequencing: present and future , 2015, Oncogene.

[43]  L. O’Driscoll,et al.  Neuromedin U: a multifunctional neuropeptide with pleiotropic roles. , 2015, Clinical chemistry.

[44]  Amar Gajjar,et al.  Cross-species genomics matches driver mutations and cell compartments to model ependymoma , 2010, Nature.

[45]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[46]  C. Fuller,et al.  Fluorescence In Situ Hybridization (FISH) in Diagnostic and Investigative Neuropathology , 2002, Brain pathology.

[47]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[48]  G. Reifenberger,et al.  Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas. , 1999, The American journal of pathology.

[49]  R. Kordek,et al.  CD151 in cancer progression and metastasis: a complex scenario , 2014, Laboratory Investigation.